BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 22493393)

  • 1. Serum levels of hypothalamic-pituitary-testicular axis hormones in men with or without prostate cancer or atypical small acinar proliferation.
    Schmitt Cda S; Rhoden EL; Almeida GL
    Clinics (Sao Paulo); 2011; 66(2):183-7. PubMed ID: 21484031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin and spermatogenesis: new lights on the interplay between prolactin and sperm parameters.
    Spaggiari G; Costantino F; Granata ARM; Tagliavini S; Canu G; Varani M; De Santis MC; Roli L; Trenti T; Simoni M; Santi D
    Endocrine; 2023 Aug; 81(2):330-339. PubMed ID: 37140814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous Measurements of Follicle Stimulating Hormone and Total Testosterone and Associations in Clinically Localized Prostate Cancer.
    Porcaro AB; Siracusano S; de Luyk N; Corsi P; Sebben M; Tafuri A; Processali T; Inverardi D; Cacciamani G; Mattevi D; Cerruto MA; Brunelli M; Ghimenton C; Monaco C; Artibani W
    Curr Urol; 2017 Nov; 10(4):174-181. PubMed ID: 29234259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of trend in the role of national and regional hubs in prostatectomy after prostate cancer diagnosis in the past 5 years: A nationwide population-based study.
    Kim SC; Han S; Yoon JH; Park S; Moon KH; Cheon SH; Park GM; Kwon T
    Investig Clin Urol; 2024 Mar; 65(2):124-131. PubMed ID: 38454821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone, prolactin, and oncogenic regulation of the prostate gland. A new concept: Testosterone-independent malignancy is the development of prolactin-dependent malignancy!
    Costello LC; Franklin RB
    Oncol Rev; 2018 Jul; 12(2):356. PubMed ID: 30093983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic treatment, prolactin, and breast tumorigenesis.
    De Hert M; Vancampfort D; Stubbs B; Sabbe T; Wildiers H; Detraux J
    Psychiatr Danub; 2016 Sep; 28(3):243-254. PubMed ID: 27658833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis and fracture risk in people with schizophrenia.
    Kishimoto T; De Hert M; Carlson HE; Manu P; Correll CU
    Curr Opin Psychiatry; 2012 Sep; 25(5):415-29. PubMed ID: 22744405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression and anxiety in recurrent giant cell tumor of bone.
    Jidveian Popescu M; Stoicea MC; Marinescu I; Cismaşiu RS; Stovicek PO; Tudose C; Ciobanu AM
    Rom J Morphol Embryol; 2020; 61(4):1057-1065. PubMed ID: 34171055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostatic cancer.
    Blacklock NJ
    Urol Res; 1977; 5(1):1-5. PubMed ID: 324081
    [No Abstract]   [Full Text] [Related]  

  • 10. [Physical activity for primary prevention of prostate cancer. Possible mechanisms].
    Heitkamp HC; Jelas I
    Urologe A; 2012 Apr; 51(4):527-32. PubMed ID: 22278169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigative clinical study on prostate cancer part VIII: prolactin hormone and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population after radical prostatectomy.
    Porcaro AB; Ghimenton C; Petrozziello A; Migliorini F; Romano M; Sava T; Caruso B; Cocco C; Antoniolli SZ; Lacola V; Rubilotta E; Monaco C; Comunale L
    Anticancer Res; 2012 Apr; 32(4):1499-506. PubMed ID: 22493393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigative clinical study on prostate cancer part IX and X: estradiol and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population after radical prostatectomy.
    Porcaro AB; Ghimenton C; Petrozziello A; Sava T; Migliorini F; Romano M; Caruso B; Cocco C; Antoniolli SZ; Lacola V; Rubilotta E; Monaco C
    Anticancer Res; 2012 Oct; 32(10):4523-32. PubMed ID: 23060581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigative clinical study on prostate cancer part VII: prolactin and the pituitary-testis-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population.
    Porcaro AB; Ghimenton C; Petrozziello A; Migliorini F; Romano M; Sava T; Caruso B; Cocco C; Antoniolli SZ; Lacola V; Rubilotta E; Monaco C; Comunale L
    Anticancer Res; 2011 Nov; 31(11):3913-20. PubMed ID: 22110219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigative clinical study on prostate cancer part VI: Follicle-stimulating hormone and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population.
    Porcaro AB; Migliorini F; Petrozziello A; Sava T; Romano M; Caruso B; Cocco C; Ghimenton C; Zecchinini Antoniolli S; Lacola V; Rubilotta E; Monaco C; Comunale L
    Urol Int; 2012; 88(2):150-7. PubMed ID: 22205171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follicle-stimulating hormone and the pituitary-testicular-prostate axis at the time of initial diagnosis of prostate cancer and subsequent cluster selection of the patient population undergoing standard radical prostatectomy.
    Porcaro AB; Migliorini F; Petrozziello A; Sava T; Romano M; Caruso B; Cocco C; Ghimenton C; Zecchinini Antoniolli S; Lacola V; Rubilotta E; Monaco C; Comunale L
    Urol Int; 2013; 90(1):45-55. PubMed ID: 23128438
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.